Working… Menu

A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease (DED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03598699
Recruitment Status : Completed
First Posted : July 26, 2018
Last Update Posted : January 13, 2021
ORA, Inc.
Information provided by (Responsible Party):
AxeroVision, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 12, 2021
Actual Study Completion Date : January 12, 2021